PETMED EXPRESS INC (PETS) Stock Fundamental Analysis
NASDAQ:PETS - Nasdaq - US7163821066 - Common Stock - Currency: USD
Taking everything into account, PETS scores 4 out of 10 in our fundamental rating. PETS was compared to 120 industry peers in the Specialty Retail industry. PETS has a great financial health rating, but its profitability evaluates not so good. PETS does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year PETS was profitable.
PETS had a positive operating cash flow in the past year.
PETS had positive earnings in 4 of the past 5 years.
In the past 5 years PETS always reported a positive cash flow from operatings.
1.2 Ratios
PETS has a Return On Assets (0.25%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of 0.37%, PETS is in line with its industry, outperforming 55.83% of the companies in the same industry.
PETS's Return On Invested Capital of 1.24% is in line compared to the rest of the industry. PETS outperforms 43.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.25% | ||
| ROE | 0.37% | ||
| ROIC | 1.24% |
ROA(3y)2.57%
ROA(5y)8.14%
ROE(3y)2.43%
ROE(5y)9.77%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 0.14%, PETS is in line with its industry, outperforming 49.17% of the companies in the same industry.
Looking at the Operating Margin, with a value of 0.62%, PETS is doing worse than 60.83% of the companies in the same industry.
PETS has a worse Gross Margin (27.68%) than 70.83% of its industry peers.
In the last couple of years the Gross Margin of PETS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.62% | ||
| PM (TTM) | 0.14% | ||
| GM | 27.68% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.27%
GM growth 5Y-3.61%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PETS is destroying value.
The number of shares outstanding for PETS has been increased compared to 1 year ago.
Compared to 5 years ago, PETS has more shares outstanding
PETS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 3.60 indicates that PETS is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.60, PETS belongs to the top of the industry, outperforming 82.50% of the companies in the same industry.
There is no outstanding debt for PETS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 3.6 |
ROIC/WACC0.13
WACC9.53%
2.3 Liquidity
PETS has a Current Ratio of 1.43. This is a normal value and indicates that PETS is financially healthy and should not expect problems in meeting its short term obligations.
PETS has a Current ratio of 1.43. This is comparable to the rest of the industry: PETS outperforms 55.00% of its industry peers.
A Quick Ratio of 1.18 indicates that PETS should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.18, PETS is doing good in the industry, outperforming 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.43 | ||
| Quick Ratio | 1.18 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 102.56% over the past year.
The Revenue for PETS has decreased by -10.82% in the past year. This is quite bad
The Revenue has been decreasing by -0.17% on average over the past years.
EPS 1Y (TTM)102.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70%
Revenue 1Y (TTM)-10.82%
Revenue growth 3Y-3.13%
Revenue growth 5Y-0.17%
Sales Q2Q%-18.88%
3.2 Future
Based on estimates for the next years, PETS will show a very strong growth in Earnings Per Share. The EPS will grow by 29.72% on average per year.
The Revenue is expected to decrease by -7.74% on average over the next years.
EPS Next Y153.62%
EPS Next 2Y34.31%
EPS Next 3Y29.72%
EPS Next 5YN/A
Revenue Next Year-17.16%
Revenue Next 2Y-9.97%
Revenue Next 3Y-7.74%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 367.00, the valuation of PETS can be described as expensive.
PETS's Price/Earnings ratio is a bit more expensive when compared to the industry. PETS is more expensive than 60.00% of the companies in the same industry.
PETS's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.60.
PETS is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 367 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, PETS is valued cheaply inside the industry as 90.00% of the companies are valued more expensively.
PETS's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 88.68 | ||
| EV/EBITDA | 3.07 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PETS does not grow enough to justify the current Price/Earnings ratio.
PETS's earnings are expected to grow with 29.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.39
PEG (5Y)N/A
EPS Next 2Y34.31%
EPS Next 3Y29.72%
5. Dividend
5.1 Amount
No dividends for PETS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
3.67
-0.05 (-1.34%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners44.55%
Inst Owner Change-10.94%
Ins Owners8.21%
Ins Owner Change7.74%
Market Cap75.82M
Analysts42.86
Price Target3.67 (0%)
Short Float %8.72%
Short Ratio8.02
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.59
Dividend Growth(5Y)-11.13%
DP54.34%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-96.08%
Min EPS beat(2)-488.23%
Max EPS beat(2)296.08%
EPS beat(4)2
Avg EPS beat(4)-36.55%
Min EPS beat(4)-488.23%
Max EPS beat(4)296.08%
EPS beat(8)3
Avg EPS beat(8)-169.93%
EPS beat(12)4
Avg EPS beat(12)-128.55%
EPS beat(16)4
Avg EPS beat(16)-101.84%
Revenue beat(2)0
Avg Revenue beat(2)-12.18%
Min Revenue beat(2)-12.84%
Max Revenue beat(2)-11.51%
Revenue beat(4)1
Avg Revenue beat(4)-8.81%
Min Revenue beat(4)-12.84%
Max Revenue beat(4)0.31%
Revenue beat(8)1
Avg Revenue beat(8)-6.94%
Revenue beat(12)1
Avg Revenue beat(12)-6.81%
Revenue beat(16)1
Avg Revenue beat(16)-6.96%
PT rev (1m)0%
PT rev (3m)-4%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 367 | ||
| Fwd PE | N/A | ||
| P/S | 0.31 | ||
| P/FCF | 88.68 | ||
| P/OCF | 15.69 | ||
| P/B | 0.79 | ||
| P/tB | 1.39 | ||
| EV/EBITDA | 3.07 |
EPS(TTM)0.01
EY0.27%
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)0.04
FCFY1.13%
OCF(TTM)0.23
OCFY6.37%
SpS11.96
BVpS4.66
TBVpS2.64
PEG (NY)2.39
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.25% | ||
| ROE | 0.37% | ||
| ROCE | 1.57% | ||
| ROIC | 1.24% | ||
| ROICexc | 2.57% | ||
| ROICexgc | 23.86% | ||
| OM | 0.62% | ||
| PM (TTM) | 0.14% | ||
| GM | 27.68% | ||
| FCFM | 0.35% |
ROA(3y)2.57%
ROA(5y)8.14%
ROE(3y)2.43%
ROE(5y)9.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.27%
GM growth 5Y-3.61%
F-Score7
Asset Turnover1.71
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 57.96% | ||
| Cap/Sales | 1.61% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 57.63% | ||
| Profit Quality | 239.5% | ||
| Current Ratio | 1.43 | ||
| Quick Ratio | 1.18 | ||
| Altman-Z | 3.6 |
F-Score7
WACC9.53%
ROIC/WACC0.13
Cap/Depr(3y)91.99%
Cap/Depr(5y)95.64%
Cap/Sales(3y)1.43%
Cap/Sales(5y)1.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)102.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70%
EPS Next Y153.62%
EPS Next 2Y34.31%
EPS Next 3Y29.72%
EPS Next 5YN/A
Revenue 1Y (TTM)-10.82%
Revenue growth 3Y-3.13%
Revenue growth 5Y-0.17%
Sales Q2Q%-18.88%
Revenue Next Year-17.16%
Revenue Next 2Y-9.97%
Revenue Next 3Y-7.74%
Revenue Next 5YN/A
EBIT growth 1Y111.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year161.4%
EBIT Next 3Y51.6%
EBIT Next 5YN/A
FCF growth 1Y-96.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-81.97%
OCF growth 3Y-52.42%
OCF growth 5Y-37.46%